Stonepine Capital Management, LLC Quant / Systematic

Name: Stonepine Capital Management, LLC Q3 2017 13F Filing | 13F Explorer
Creator: Stonepine Capital Management, LLC
Published: 2017-11-13

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q3 2017 (← Previous) (Next →)

Filing Date: Nov 13, 2017

Total Value: $170M (100.0% shares, 0.0% debt)

Holdings (22)

— VIVEVE MEDICAL INC 11.9%

Value $20.17M Shares 3,849,711 Est. Cost $6.92 Unrealized —

ENTA ENANTA PHARMACEUTICALS INC 10.8%

Value $18.25M Shares 390,000 Est. Cost $30.74 Unrealized +30.8%

PCRX PACIRA PHARMACEUTICALS INC 8.3%

Value $14.09M Shares 375,200 Est. Cost $40.24 Unrealized 0.0%

— RECRO PHARMA INC 7.7%

Value $13.07M Shares 1,455,818 Est. Cost $8.20 Unrealized —

— NOVELION THERAPEUTICS INC 7.6%

Value $12.84M Shares 1,826,364 Est. Cost $8.59 Unrealized —

— BIODELIVERY SCIENCES INTL 6.7%

Value $11.41M Shares 3,867,400 Est. Cost $2.05 Unrealized —

— APOLLO ENDOSURGERY INC 6.5%

Value $11.07M Shares 2,364,707 Est. Cost $4.68 Unrealized —

— AVADEL PHARMACEUTICALS PLC 6.1%

Value $10.35M Shares 985,210 Est. Cost $9.88 Unrealized —

— OPHTHOTECH CORP 5.8%

Value $9.834M Shares 3,487,209 Est. Cost $4.39 Unrealized —

— BIOSPECIFICS TECHNOLOGIES 5.8%

Value $9.833M Shares 211,370 Est. Cost $47.37 Unrealized —

CPIX CUMBERLAND PHARMACEUTICALS 5.3%

Value $8.982M Shares 1,272,191 Est. Cost $5.77 Unrealized +19.9%

— CARDIOME PHARMA CORP 3.6%

Value $6.106M Shares 2,866,785 Est. Cost $2.61 Unrealized —

VCEL VERICEL CORP 3.5%

Value $5.854M Shares 975,711 Est. Cost $2.65 Unrealized +44.7%

VNDA VANDA PHARMACEUTICALS INC 3.2%

Value $5.37M Shares 300,000 Est. Cost $14.40 Unrealized +16.2%

— CTI BIOPHARMA CORP 1.9%

Value $3.168M Shares 993,000 Est. Cost $3.31 Unrealized —

VCYT VERACYTE INC 1.7%

Value $2.894M Shares 330,000 Est. Cost $7.70 Unrealized +5.6%

— OXFORD IMMUNOTEC GLOBAL PLC 1.6%

Value $2.726M Shares 162,286 Est. Cost $16.80 Unrealized —

— INTERCEPT PHARMACEUTICALS IN 0.6%

Value $1.08M Shares 18,600 Est. Cost $58.06 Unrealized —

— CAS MEDICAL SYSTEMS INC 0.4%

Value $748K Shares 812,718 Est. Cost $1.16 Unrealized —

— TRINITY BIOTECH PLC 0.4%

Value $688K Shares 122,668 Est. Cost $6.92 Unrealized —

— ALIMERA SCIENCES INC 0.4%

Value $644K Shares 477,226 Est. Cost $1.31 Unrealized —

— COMBIMATRIX CORP 0.3%

Value $475K Shares 63,283 Est. Cost $7.51 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	VIVEVE MEDICAL INC	3,849,711	$20.17M	11.9%	$6.92	—	COM NEW	92852W204
ENTA	ENANTA PHARMACEUTICALS INC	390,000	$18.25M	10.8%	$30.74	+30.8%	COM	29251M106
PCRX	PACIRA PHARMACEUTICALS INC	375,200	$14.09M	8.3%	$40.24	0.0%	COM	695127100
—	RECRO PHARMA INC	1,455,818	$13.07M	7.7%	$8.20	—	COM	75629F109
—	NOVELION THERAPEUTICS INC	1,826,364	$12.84M	7.6%	$8.59	—	COM NEW	67001K202
—	BIODELIVERY SCIENCES INTL	3,867,400	$11.41M	6.7%	$2.05	—	COM	09060J106
—	APOLLO ENDOSURGERY INC	2,364,707	$11.07M	6.5%	$4.68	—	COM	03767D108
—	AVADEL PHARMACEUTICALS PLC	985,210	$10.35M	6.1%	$9.88	—	SPONSORED ADR	05337M104
—	OPHTHOTECH CORP	3,487,209	$9.834M	5.8%	$4.39	—	COM	683745103
—	BIOSPECIFICS TECHNOLOGIES	211,370	$9.833M	5.8%	$47.37	—	COM	090931106
CPIX	CUMBERLAND PHARMACEUTICALS	1,272,191	$8.982M	5.3%	$5.77	+19.9%	COM	230770109
—	CARDIOME PHARMA CORP	2,866,785	$6.106M	3.6%	$2.61	—	COM NO PAR	14159U301
VCEL	VERICEL CORP	975,711	$5.854M	3.5%	$2.65	+44.7%	COM	92346J108
VNDA	VANDA PHARMACEUTICALS INC	300,000	$5.37M	3.2%	$14.40	+16.2%	COM	921659108
—	CTI BIOPHARMA CORP	993,000	$3.168M	1.9%	$3.31	—	COM NEW	12648L601
VCYT	VERACYTE INC	330,000	$2.894M	1.7%	$7.70	+5.6%	COM	92337F107
—	OXFORD IMMUNOTEC GLOBAL PLC	162,286	$2.726M	1.6%	$16.80	—	ORD SHS	G6855A103
—	INTERCEPT PHARMACEUTICALS IN	18,600	$1.08M	0.6%	$58.06	—	COM	45845P108
—	CAS MEDICAL SYSTEMS INC	812,718	$748K	0.4%	$1.16	—	COM PAR	124769209
—	TRINITY BIOTECH PLC	122,668	$688K	0.4%	$6.92	—	SPON ADR NEW	896438306
—	ALIMERA SCIENCES INC	477,226	$644K	0.4%	$1.31	—	COM	016259103
—	COMBIMATRIX CORP	63,283	$475K	0.3%	$7.51	—	COM PAR	20009T501